Published 1 year ago

Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conference

Summary by Ground News

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative medicines based on cancer cell biology. Spiro Rombotis, President and Chief Executive Officer, is scheduled to present an overview of Cyclacel's business and clinical programs at the BIO CEO & Investor Conference on February 6-9, 2023.

0 Articles

All

Left

Center

Right

Benzinga

Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conference

BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP, ", Cyclacel", or the ", Company", )), a biopharmaceutical company developing innovative

1 year ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.